Zobrazeno 1 - 10 of 26 pro vyhledávání: '"Francisco, Sanz Herrero"'
1
Ceftazidime-avibactam
Autor: Francisco Sanz Herrero
Publikováno v: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia. 35
The increase in nosocomial infections by beta-lactamase producing Gram-negative bacilli constitutes a therapeutic challenge. The combination of ceftazidime-avibactam offers a very interesting therapeutic option for nosocomial pneumonia caused by exte
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfe0303124e4771fdf3fb41f9bf33686
https://pubmed.ncbi.nlm.nih.gov/35488824
Zobrazit plný text záznamu
4
Abnormal liver chemistry constitutes an independent prognostic factor of less favorable clinical course in patients with COVID-19
Autor: Carlos Alventosa Mateu, Salvador Benlloch Pérez, Miguel García Deltoro, Mercedes Latorre Sánchez, Francisco Sanz Herrero, Juan José Urquijo Ponce, Moisés Diago Madrid, Concepción Gimeno Cardona, María Dolores Ocete Mochón, Francesc Puchades Gimeno
Publikováno v: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva. 113(12)
INTRODUCTION: Abnormal liver biochemistry (ALB) is correlated with increased clinical involvement or severity in COVID-19, but its prognostic implications have not been studied extensively. Our aim is to determine whether ALB is a risk factor for an
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e285c3801dcf25b2718236839d2343d5
https://pubmed.ncbi.nlm.nih.gov/34157846
Zobrazit plný text záznamu
6
Circulating microRNAs can identify endotypes of community-acquired pneumonia
Autor: Francisco Sanz Herrero, Araceli Aibar, Francisco Jose Dasi Fernandez, Jessica Lozada, María Luisa Briones, Estrella Fernández Fabellas, Santos Ferrer, Silvia Vicente Ferrer, M. Martinez
Publikováno v: Respiratory infections.
Background: The identification of the host processes dysregulated in community-acquired pneumonia (CAP) patients, especially in those who develop severe complications could be crucial for future management of this disease. We aim to study microRNAs p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2324a5a01deaca0e68230d73d6cb130c
https://doi.org/10.1183/13993003.congress-2019.pa5449
Zobrazit plný text záznamu
8
Survival benefit of beta-lactam plus macrolide combined therapy versus beta-lactam plus quinolones in hospitalized community-acquired pneumonia
Autor: María Luisa Briones, Eusebi Chiner, María Carmen Aguar, Estrella Fernández-Fabrellas, Ruben Lera, Angela Cervera, José Blanquer, Francisco Sanz Herrero
Publikováno v: 10.1 Respiratory Infections.
Background: Guidelines do not state a specific advantage regarding the addition of macrolides or quinolones to beta-lactams in empirical combined antibiotic therapy. But little is known if there exists a survival benefit of the different regimes. We
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3b8afb563418d844d7f029bca295ce87
https://doi.org/10.1183/13993003.congress-2016.oa3327
Zobrazit plný text záznamu
9
Microbiology and Risk Factors for Community-Acquired Pneumonia
Autor: Francisco Sanz Herrero, Jose Blanquer Olivas
Publikováno v: Seminars in Respiratory and Critical Care Medicine. 33:220-231
The outcome of community-acquired pneumonia (CAP) depends on the interaction between the infectious agent and the host response. Nowadays the etiology of CAP can be established in ~60% of the cases, and Streptococcus pneumoniae remains the main etiol
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9eafd9c3d8305436cb32302fa568e93
https://doi.org/10.1055/s-0032-1315634
Zobrazit plný text záznamu
10
Nuevos retos en la neumonía comunitaria
Autor: Francisco Sanz Herrero, Nuria Marina Malanda, Beatriz Montull Veiga, María Pilar Sanjuán López
Publikováno v: Archivos de Bronconeumología. 46:22-26
Community-acquired pneumonia is a major cause of morbidity and mortality. Severity assessment is a fundamental tool in the management of pneumonia that allows patients to be stratified according to risk of death and the most appropriate treatment int
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aecf9e072127131769a334c3da32263c
https://doi.org/10.1016/s0300-2896(10)70039-9
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje